PRVA

Business Context and Reporting Period

Company: Privia Health Group, Inc. (NASDAQ: PRVA)
Filing Type: Form 10-K (Annual Report)
Reporting Period: Year ended December 31, 2024
Business Overview: Privia Health is a technology-driven, national physician-enablement company that organizes physicians into regional Medical Groups to transition care from fee-for-service (FFS) to value-based care (VBC). The company operates in 15 markets across 14 states and the District of Columbia, utilizing a cloud-based technology platform to manage clinical operations, revenue cycle management, and population health.

Key Financial Metrics

Key Non-GAAP Margins:
- Care Margin: $403.9 million (23.3% of revenue)
- Platform Contribution Margin: 48.4% of Care Margin
- Adjusted EBITDA Margin: 22.4% of Care Margin

Material Changes vs. Prior Period

• Revenue Growth: Total revenue increased 4.7% year-over-year to $1.74 billion. This was driven by a 17.4% increase in FFS-patient care revenue and a 26.8% increase in Care management fees (PMPM).
• Capitated Revenue Decline: Capitated revenue decreased 37.1% to $213.0 million. Management attributes this to the renegotiation of certain at-risk capitation agreements in Q1 2024 for more favorable contract structures, shifting revenue recognition to shared savings.
• Profitability: Net income attributable to Privia decreased 37.7% to $14.4 million, primarily due to a 52.8% increase in stock-based compensation expense ($56.7 million in 2024 vs. $37.1 million in 2023) and higher general and administrative costs.
• Operating Expenses: Total operating expenses rose 5.0% to $1.72 billion. "Cost of platform" increased 14.8% due to higher salaries, stock-based compensation, and platform costs associated with growth.
• Cash Flow: Net cash provided by operating activities increased 35.3% to $109.3 million, driven by changes in provider liability and accounts receivable.

Guidance, Outlook, and Risks

Management Commentary & Outlook:
- The company continues to focus on organic growth in existing markets and expansion into new geographies (entered Indiana in late 2024).
- Strategy emphasizes transitioning markets from FFS to VBC models to capture shared savings and improve per-patient economics.
- Implemented Providers grew 11.2% to 4,789, and Attributed Lives increased 12.1% to 1.26 million.

Key Risks and Contingencies:
- Regulatory & Compliance: Significant exposure to federal and state healthcare laws (Stark Law, Anti-Kickback Statute, HIPAA). Changes in Medicare Advantage risk adjustment models or CMS audits could materially impact revenue.
- Reimbursement Risk: Dependence on third-party payers; potential for reduced reimbursement rates or contract non-renewals.
- Technology & Cybersecurity: Reliance on a single EMR vendor (athenahealth) and exposure to cybersecurity threats.
- Profitability: History of net losses prior to 2023; future profitability depends on managing growth expenses and stock-based compensation.

Investor Verification Checklist

• Revenue Mix Shift: Verify the long-term impact of renegotiated capitation agreements on future revenue stability and the sustainability of the shift from capitated revenue to shared savings.
• Stock-Based Compensation: Assess the trajectory of stock-based compensation expenses ($56.7M in 2024) and its impact on future GAAP net income.
• Provider Retention: Confirm the 96% provider retention rate and the ability to maintain this rate as the company scales into new markets.
• Debt Covenants: Review the restrictive covenants in the $125 million Revolving Credit Facility, even though no debt is currently outstanding.
• Regulatory Audits: Monitor for any CMS Risk Adjustment Data Validation (RADV) audits or findings related to Medicare Advantage attributed lives.